MENU

GLUE Monte Rosa Therapeutics Forecast, Technical & Fundamental Analysis

Monte Rosa Therapeutics Inc is a clinical-stage biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins... Show more

GLUE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
GLUE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

GLUE is expected to report earnings to fall 15.33% to -36 cents per share on November 05

Monte Rosa Therapeutics GLUE Stock Earnings Reports
Q3'26
Est.
$-0.36
Q2'26
Missed
by $0.05
Q1'26
Missed
by $0.03
Q4'25
Missed
by $0.10
Q3'25
Beat
by $0.03
The last earnings report on August 06 showed earnings per share of -43 cents, missing the estimate of -37 cents. With 447.91K shares outstanding, the current market capitalization sits at 1.18B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
321 Harrison Avenue
Phone
+1 617 949-2643
Employees
150
Web
https://www.monterosatx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DTGRX87.331.41
+1.64%
BNY Mellon Technology Growth A
PVIVX56.530.71
+1.27%
Paradigm Micro-Cap
FSFJX45.860.16
+0.35%
Fidelity Advisor Focused Stock M
AFIFX103.61-0.02
-0.02%
American Funds Fundamental Invs F-1
CCASX65.57-0.09
-0.14%
Conestoga Small Cap Investors

GLUE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, GLUE has been loosely correlated with AXON. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if GLUE jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLUE
1D Price
Change %
GLUE100%
-3.76%
AXON - GLUE
38%
Loosely correlated
-4.18%
RVMD - GLUE
38%
Loosely correlated
-0.40%
CCCC - GLUE
37%
Loosely correlated
+0.53%
KURA - GLUE
36%
Loosely correlated
+0.76%
ARRY - GLUE
36%
Loosely correlated
+1.32%
More
Monte Rosa Therapeutics (GLUE) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com